Ollie's CEO executes 4,000 options and sells shares under 10b5-1 plan

Rhea-AI Filing Summary

Eric van der Valk, President and CEO of Ollie's Bargain Outlet Holdings, Inc. (OLLI), reported option exercise and share sales on 09/29/2025 executed under a Rule 10b5-1 plan adopted June 30, 2025. He exercised 4,000 employee stock options with a $43.21 exercise price and acquired 4,000 common shares. Immediately, he sold 4,000 common shares in multiple transactions for a weighted average price of $132.27 per share. After these transactions he beneficially owns 7,761 shares directly and holds 4,000 underlying shares from the exercised options, for a reported total of 11,761 shares noted in the non-derivative table and 11,536 shares reported in derivative ownership context. The filing discloses the option grant size (18,457 options) and the vesting schedule with installments through March 25, 2026, and an expiration/related date of March 25, 2032.

Positive

• Transactions executed under a Rule 10b5-1 plan, adopted June 30, 2025, providing a prearranged, documented framework for trades
• Clear disclosure of option grant size and vesting schedule (18,457 options with installment vesting through March 25, 2026), improving transparency
• Sale price disclosed as a weighted average ($132.27) with range provided ($131.01–$133.05), giving detailed pricing information

Negative

• Reduction in direct beneficial ownership following sale: direct holdings reported at 7,761 shares after the transactions
• Material portion of exercised shares sold immediately, indicating insider liquidity rather than retention of exercised shares

Insights

Securities Analyst

TL;DR: Routine executive option exercise and prearranged sale under a 10b5-1 plan; reduces direct holdings but follows a documented trading plan.

The filing documents a standard exercise of 4,000 employee stock options at a $43.21 strike and contemporaneous sale of 4,000 shares at a weighted average of $132.27 under a Rule 10b5-1 agreement adopted June 30, 2025. The transactions are consistent with liquidity-taking by an executive rather than a company-level corporate event. The report also reconfirms the total option grant size (18,457 options) and vesting cadence, which affects future potential dilution and insider holdings over the next vesting dates.

Corporate Governance Expert

TL;DR: Disclosure aligns with governance best practices: 10b5-1 plan used and signature provided by attorney-in-fact.

The form clearly states the use of a Rule 10b5-1 trading plan adopted June 30, 2025, and includes an attorney-in-fact signature, improving defensibility of the trades against timing concerns. The filing lists precise quantities, weighted average sale price range, and vesting schedule for outstanding options, which aids transparency about executive compensation realization and current insider ownership levels.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

van der Valk Eric

(Last) (First) (Middle)

C/O OLLIE'S BARGAIN OUTLET HOLDINGS, INC

6295 ALLENTOWN BOULEVARD, SUITE 1

(Street)

HARRISBURG PA 17112

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Ollie's Bargain Outlet Holdings, Inc. [ OLLI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President and CEO

3. Date of Earliest Transaction (Month/Day/Year)
09/29/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, par value $0.001 per share	09/29/2025		M(1)		4,000	A	$43.21	11,761	D
Common Stock, par value $0.001 per share	09/29/2025		S(1)		4,000	D	$132.27(2)	7,761	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (right to buy)	$43.21	09/29/2025		M(1)			4,000	(3)	03/25/2032	Common Stock	4,000	$0	11,536	D

Explanation of Responses:

1. Transactions made pursuant to an agreement adopted on June 30, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

2. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $131.01-133.05, inclusive. The reporting person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

3. Options vest and become exercisable in 25% installments on each anniversary date of the grant, March 25, 2022, subject to continued service through each applicable vesting date. The reporting person was granted 18,457 options, of which 4,614 vested on March 25, 2023; 4,615 vested on March 25, 2024; 4,614 vested on March 25, 2025; and 4,614 vest on March 25, 2026.

Remarks:

	/s/ James J. Comitale as Attorney-In-Fact	09/30/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transactions did OLLI director and CEO Eric van der Valk report on Form 4?

The filing reports the exercise of 4,000 employee stock options at a $43.21 strike and the sale of 4,000 shares on 09/29/2025 executed under a Rule 10b5-1 plan.

Was the sale part of a 10b5-1 trading plan for OLLI insider trades?

Yes. The transactions were made pursuant to a Rule 10b5-1 agreement adopted June 30, 2025, as disclosed in the Form 4.

What price did Eric van der Valk receive for the sold shares reported on Form 4?

The shares were sold at a weighted average price of $132.27 per share, with individual sale prices ranging from $131.01 to $133.05.

How many options does the reporting person hold and what is the vesting schedule?

The report states a grant of 18,457 options with 25% vesting installments annually beginning March 25, 2023 and concluding with an installment on March 25, 2026; exercisability and an expiration-related date are noted through March 25, 2032.

How many shares does Eric van der Valk beneficially own after these transactions?

The Form 4 shows 7,761 shares directly owned after the sale and references 11,761 shares in another ownership line; derivative tables show 4,000 underlying shares from exercised options.